leisure time -WSS

leisure time

author：Wikipedia 2025-09-27 19:37:59 - browse：23566

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： FDA panel signals lack of confidence in Amgen cancer drug data

focus

entertainment

WSS

Histogen: Failed biotech offers rare public look inside

VC firm General Catalyst wants to buy a health system

He's 19 months old and has one of the world’s rarest diseases

Senate panel eyes new effort on drug shortages

Bristol 'take

Harvard's David Sinclair gets blowback over aging

focus

leisure time

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

A virus, fished out of a lake, may have saved a man’s life

Hepatitis C has a cure — but many Americans still lack access to it

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Tori Bowie and the unacceptable rates of Black maternal death

What to expect at HLTH 2023, the health care industry conference

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Chan Zuckerberg Biohub Chicago to focus on inflammation

Heart attack and stroke risk calculators need revising

FDA rejects Alnylam's heart disease treatment over insufficient data

leisure time

Histogen: Failed biotech offers rare public look inside

Stem cell biologist probes earliest stages of human development

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

AI can decode, harness the power of the humane immune system

Histogen: Failed biotech offers rare public look inside

For AI in health care standards, federal regulators join with industry group

focus

entertainment

focus

leisure time